IDWeek 2024
Rezafungin Sees Good Efficacy and Safety for Candidemia or Invasive Candidiasis
New data found that one dose of rezafungin demonstrated good safety and efficacy compared with caspofungin to treat ...
FEBRUARY 21, 2025
Biktarvy’s Benefits Extend in Older Adults With HIV
Five-year follow-up data from the triple combination HIV therapy showed high rates of disease suppression and ...
FEBRUARY 20, 2025
A Branded Antibiotic May Be Cost-Effective
When acute bacterial skin and skin structure infections are not cured by oral antibiotics, many health systems opt ...
DECEMBER 23, 2024
Biktarvy’s Benefits Extend in Older Adults With HIV
Five-year follow-up data from the triple combination HIV therapy bictegravir-emtricitabine-tenofavir alafenamide ...
NOVEMBER 25, 2024
CNS Involvement in Immunocompromised Shingles Patients: Don’t Miss the Subtle Signs
A retrospective case series study of immunocompromised patients with active herpes zoster infections who presented ...
NOVEMBER 22, 2024
Improving HBV Screening Before Switching to 2-Drug HIV Regimens
Implementation of a best-practice alert in the EHR led to a significant decrease in switches to two-drug ART among ...
NOVEMBER 15, 2024
Immigrants With Chronic HBV Are Vulnerable to Lapses in Antiviral Use
Due to multiple factors, immigrants living in the United States who have chronic hepatitis B virus (HBV) are ...
NOVEMBER 8, 2024
Negative Results on BioFire Pneumonia Panel Allow Antibiotic Discontinuation
A rapid multiplexed molecular panel facilitated safe discontinuation of antibiotic therapy in patients with ...
OCTOBER 25, 2024
Wastewater Surveillance Found Avian Flu Before Reported Outbreaks in Cattle
Avian influenza was detected by wastewater surveillance before the first reported outbreak among Texas dairy cattle ...
OCTOBER 19, 2024
More Than Half Of Medicaid-Insured Infants At-Risk for HIV Received No Perinatal Prophylaxis
More than half of Medicaid-insured infants diagnosed with HIV did not receive postnatal antiretroviral prophylaxis ...
OCTOBER 18, 2024
Cefiderocol Proves Efficacious, Well Tolerated in Real-World Data
PROVE trial results show Fetroja was efficacious and well tolerated in the treatment of serious gram-negative ...
OCTOBER 18, 2024
IDWeek Spotlights New Rapid ID Diagnostics in the Pipeline
Three promising new rapid infectious disease diagnostic assays took the stage at IDWeek 2024, in Los Angeles.
OCTOBER 18, 2024
